{"transactions":[{"id":1142935,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":79603,"kind":"organization","name":"ACORN BIOVENTURES, L.P.","position":1,"cik":"0001766853","reported_name":"ACORN BIOVENTURES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79604,"kind":"organization","name":"ACORN CAPITAL ADVISORS GP, LLC","position":2,"cik":"0001813692","reported_name":"ACORN CAPITAL ADVISORS GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T16:43:34.000Z","date":"2025-05-15","kind":"purchase","planned":false,"acquired":true,"shares":1129730,"price":1.85,"value":2090000.5,"ownership":{"direct":false,"nature":"By Acorn Bioventures 2, L.P."},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Shares held directly by Acorn Bioventures 2, L.P. (\"Acorn 2\"). Acorn Capital Advisors GP 2, LLC (\"Acorn GP 2\") is the general partner of Acorn 2. Anders Hove is the manager of Acorn GP 2. Each of Acorn GP 2 and Mr. Hove disclaims beneficial ownership of disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":1129730,"source":{"system":"sec-edgar","filing":"0000950170-25-074459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813692/000095017025074459/ownership.xml","form_type":"4"}},{"id":1142934,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":79603,"kind":"organization","name":"ACORN BIOVENTURES, L.P.","position":1,"cik":"0001766853","reported_name":"ACORN BIOVENTURES, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79604,"kind":"organization","name":"ACORN CAPITAL ADVISORS GP, LLC","position":2,"cik":"0001813692","reported_name":"ACORN CAPITAL ADVISORS GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-05-19T16:43:34.000Z","date":"2025-05-15","kind":"purchase","planned":false,"acquired":true,"shares":270270,"price":1.85,"value":499999.5,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Shares held directly by Acorn Bioventures, L.P. (\"Acorn\"). Acorn Capital Advisors GP, LLC (\"Acorn GP\") is the general partner of Acorn. Anders Hove is the manager of Acorn GP. Each of Acorn GP and Mr. Hove disclaims beneficial ownership of disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose."}],"balance_after":1709944,"source":{"system":"sec-edgar","filing":"0000950170-25-074459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813692/000095017025074459/ownership.xml","form_type":"4"}},{"id":1665745,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":79605,"kind":"person","name":"Hove Anders D","position":1,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-31T21:25:37.000Z","date":"2024-01-30","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 30, 2024, subject to the Reporting Person continuing to provide Continuous Service (as defined in the 2020 Equity Incentive Plan) through such date. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested."}],"balance_after":6000,"derivative":{"exercise_price":1.64,"expiration_date":"2034-01-30","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-24-002481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919124002481/doc4.xml","form_type":"4"}},{"id":2082553,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":79605,"kind":"person","name":"Hove Anders D","position":1,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-12-19T21:23:17.000Z","date":"2022-12-15","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of December 15, 2022.  If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested."}],"balance_after":6000,"derivative":{"exercise_price":2.32,"expiration_date":"2032-12-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-061911","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919122061911/doc4.xml","form_type":"4"}},{"id":2908768,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":79605,"kind":"person","name":"Hove Anders D","position":1,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-01-14T00:07:09.000Z","date":"2021-01-12","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the 2020 Equity Incentive Plan, vesting in 36 equal monthly installments beginning as of December 21, 2020.  If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested."}],"balance_after":12000,"derivative":{"exercise_price":4.31,"expiration_date":"2031-01-12","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-003472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919121003472/doc4.xml","form_type":"4"}},{"id":3941036,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"exercise","acquired":false,"shares":9124088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1372043},"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":3941035,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"purchase","acquired":true,"shares":125000,"price":16,"value":2000000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":1497043,"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":3941034,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":166871,"kind":"organization","name":"Amzak Health Investors, LLC","position":1,"cik":"0001719184","reported_name":"Amzak Health Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166872,"kind":"person","name":"Kazma Michael D","position":2,"cik":"0001702237","reported_name":"Kazma Michael D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":79605,"kind":"person","name":"Hove Anders D","position":3,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-05-10T01:19:27.000Z","date":"2018-05-07","kind":"exercise","acquired":true,"shares":1372043,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series F Convertible Preferred Stock automatically converted into shares of the Issuer's Common Stock at a 1-for-0.1504 conversion rate immediately prior to the closing of the Issuer's initial public offering for no additional consideration (subject to the payment of cash in lieu of any fractional shares in accordance with the Issuer's Sixth Amended and Restated Certificate of Incorporation, as amended).  These shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held of record by Amzak Health Investors, LLC (\"Amzak Health\").  Joyce Erony, a director of the Issuer, Michael D. Kazma, and Anders Hove are managers of Amzak Health and, as a result, have shared voting and dispositive power over the shares held by Amzak Health.  Each of Ms. Erony and Mr. Hove disclaims beneficial ownership of the shares held by Amzak Health except to the extent of his or her proportionate pecuniary interest therein."}],"balance_after":1372043,"source":{"system":"sec-edgar","filing":"0001104659-18-031864","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465918031864/a4.xml","form_type":"4"}},{"id":4017299,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":79605,"kind":"person","name":"Hove Anders D","position":1,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-05T22:32:38.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the 2013 Amended and Restated Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of January 1, 2018.  If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested."}],"balance_after":8000,"derivative":{"exercise_price":0.72,"expiration_date":"2028-02-29","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-18-016685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919118016685/doc4.xml","form_type":"4"}},{"id":4437445,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":79605,"kind":"person","name":"Hove Anders D","position":1,"cik":"0001365618","reported_name":"Hove Anders D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-02-21T21:47:45.000Z","date":"2017-02-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Grant to the Reporting Person of a stock option under the 2013 Amended and Restated Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of February 16, 2017.  If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested"}],"balance_after":10000,"derivative":{"exercise_price":2.5,"expiration_date":"2027-02-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-012755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000120919117012755/doc4.xml","form_type":"4"}}]}